Brief: Verve Therapeutics Says Investigational New Drug Application For VERVE-101 Cleared by U.S. FDA
23/10/2023 12:27
Oct 23 (Reuters) - Verve Therapeutics Inc VERV.O :
* VERVE THERAPEUTICS ANNOUNCES CLEARANCE OF INVESTIGATIONAL
NEW
DRUG APPLICATION BY THE U.S. FDA FOR VERVE-101 IN PATIENTS WITH
HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
* VERVE THERAPEUTICS INC - WITH CLEARANCE OF THIS IND, WE
PLAN TO
BEGIN PROCESS OF ACTIVATING U.S. CLINICAL TRIAL SITES FOR
HEART-1 CLINICAL TRIAL
Source text for Eikon: ID:nGNX4JTvL1
Further company coverage: VERV.O
((Reuters.Briefs@thomsonreuters.com;))